Dyslipidemia Associated With Type II Diabetes Mellitus, Type 2 Diabetes Mellitus in Obese
Conditions
Keywords
type 2 diabetes mellitus, dyslipidemias, obesity, Chinese herbal medicine, retrospective review
Brief summary
This study is a retrospective review of participants who visited Department of Endocrinology, Guang'anmen Hospital and accepted traditional Chinese medicine formula for at least sis months, from January 2015 to December 2020. All the participants should be diagnosed as type 2 diabetes mellitus, obesity and dyslipidemia. Therapeutic effect of traditional Chinese medicine will be evaluated based on the changes of blood glucose, body mass index, blood lipids, and blood pressure.
Detailed description
The diagnostic criteria for type 2 diabetes mellitus and obesity are based on the Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). The diagnostic criteria of dyslipidaemia are based on the Chinese Guidelines on Prevention and Treatment of Dyslipidaemia in Adults (2016, revision edition).
Interventions
Patients took 200 ml Chinese herb decoction twice a day before breakfast and dinner.
Sponsors
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Meet at least three of the requirements below; 1) Fasting Plasma Glucose \> 6.1 mmol/L or 2-hour Postprandial Blood Glucose \> 7.8 mmol/L or diagnosed as type 2 diabetes mellitus; 2) Body Mass Index \> 25 kg / m2; 3) Total Cholesterol \> 5.2 mmol / L; Or Triglyceride \> 1.70 mmol / L; Or Low-Density Lipoprotein \> 3.12 mmol / L; Or High-Density Lipoprotein \< 1.04 mmol/L. 4) Systolic blood pressure \> 130 mmHg or Diastolic blood pressure \> 85 mmHg or diagnosed as hypertension; 2. Received 6 months of continuous Chinese herbal medicine treatment; 3. During the period of receiving Chinese herbal medicine, the patients continued to take western medicine according to the doctor's advice as before. 4. During the period of receiving Chinese herbal medicine, diet and exercise continued according to the original routine, and the tests would be reviewed in the same institution. 5. Aged 18 to 80 years at the time of their consent; 6. Signed informed consent.
Exclusion criteria
* Patients who had serious heart, lung, liver, kidney and brain diseases; serious infectious or hemorrhagic diseases; serious nervous system diseases, mental instability; or could not cooperate with treatment were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes from Baseline Body Mass Index at 3 months, 6 months | 0 month, 3 months, 6 months |
| Change from Baseline HbA1c at 3 months, 6 months | 0 month, 3 months, 6 months |
| Changes from Baseline Fasting Blood Glucose at 3 months, 6 months | 0 month, 3 months, 6 months |
| Changes from Baseline Low Density Lipoprotein at 3 months, 6 months | 0 month, 3 months, 6 months |
| Changes from Baseline Triglyceride at 3 months, 6 months | 0 month, 3 months, 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Changes from Postprandial Blood Glucose at 6 months | 0 month, 6 months |
| Changes from Total Cholesterol at 6 months | 0 month, 6 months |
| Changes from High Density Lipoprotein at 6 months | 0 month, 6 months |
| Changes from Systolic Blood Pressure at 6 months | 0 month, 6 months |
| Changes from Diastolic Blood Pressure at 6 months | 0 month, 6 months |
Countries
China
Outcome results
None listed